RecruitingType 1 Diabetes
Efficacy of Glycemic Improvement Project (GLITTER Study) in Type 1 Diabetes-GLITTER Study 2
Eligible age
6+ yrs
Accepts
All genders
Locations
0 states
Healthy volunteers
No
See if you qualify for this study
Answer a few quick questions about your location and health. Takes about a minute.
About this study
The GLITTER Study 2 is a cluster randomized trial that will evaluate the impact of comprehensive and intensive management, comprising a team, technology, education, and peer resources, on metabolic control and psychological outcomes in patients with type 1 diabetes.
Sponsor: Second Xiangya Hospital of Central South University
You may not qualify if…
- ✕ 1. Patients who plan to receive diabetes treatment at other hospitals.
- ✕ 2. Patients who have used an automated insulin delivery system or sensor-augmented pump within 3 months prior to screening.
- ✕ 3. Patients who refuse to use continuous glucose monitoring or insulin pumps, or refuse data upload and remote monitoring.
- ✕ 4. Patients with severe cardiovascular, cerebrovascular, hepatic, or renal diseases; uncontrolled systemic diseases, thyroid diseases; autoimmune diseases; or malignancies.
- ✕ 5. Patients diagnosed with hematologic or bleeding disorders.
- ✕ 6. Patients who have received red blood cell transfusions or erythropoiesis-stimulating agents within 3 months prior to screening.
- ✕ 7. Patients who have used any oral, injectable, or intravenous corticosteroids within 8 weeks prior to screening, or who plan to use corticosteroids during the trial.
- ✕ 8. Patients with severe skin diseases that may affect the application sites of continuous glucose monitoring or insulin pump patches.
Source: ClinicalTrials.gov · NCT07097818 · last updated 2025-09-03